The Blog
-
Aug 06, 2025
Decoding Cancer Epigenetics: How YTH Domain Proteins Read m6A to Rewrite Tumor Fate
READ MORE -
Jun 23, 2025
Analysis of the mechanism of action of ADC drugs
READ MORE -
May 20, 2025
Tyrosine Kinases in Cancer: From Molecular Mechanisms to Targeted Therapies
READ MORE -
May 16, 2025
KRAS-Targeted Drugs: From Discovery to Clinical Application
READ MORE -
Apr 29, 2025
Inavolisib: A Breakthrough in Cancer Treatment and PI3K Inhibitio
READ MORE -
Mar 27, 2025
Vorasidenib and Low-Grade Gliomas: A Promising New Therapy with Open Questions
READ MORE -
Feb 14, 2025
Targeting DLL3 in Small Cell Lung Cancer: New Hope for Treatment Breakthroughs
READ MORE -
Jan 23, 2025
Inavolisib: A New Hope in Targeted Therapy for HR+ HER2-Negative Breast Cancer
READ MORE -
Jan 22, 2025
Everything You Need to Know About Ensartinib for ALK-Positive Non-Small Cell Lung Cancer
READ MORE